je.st
news
Big name investors take sides on Ackman bet on Valeant: filings
2015-05-16 18:10:24| Biotech - Topix.net
With its stock up 56 percent since January, the Canadian company is giving new and existing investors plenty to cheer about. In the last 52 weeks, it has risen 80 percent, outperforming both the S&P 500 Index and the Pharmaceuticals sub-index.
Tags: big
sides
bet
investors
Category:Biotechnology and Pharmaceuticals